|
|
 |
2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
CERTs Publications
2000
- Benton RE, Sale M, Flockhart DA, Woosley RL. Greater
quinidine-induced QTc interval prolongation in women. Clin Pharmacol
Ther 2000;67:413-418.
- Desta Z, Soukhouva N, Morocho A, Park J, Mahal SK, Flockhart DA.
Stereoselective
determination of cisapride, a prokinetic agent, in human plasma by chiral
high-performance liquid chromatography with ultraviolet detection: application
to pharmacokinetic study. J Chromatography Biomed Sci Appl 2000;744:263-272.
- Flockhart DA, Desta Z, Mahal SK. Selection
of drugs to treat gastro-oesophageal reflux disease: the role of drug
interactions. Clin Pharmacokinet 2000;39:295-309.
- Flockhart DA, Oesterheld JO. Cytochrome
P450-mediated drug interactions. Child Adolesc Psychiatr Clin N Am 2000;9:43-76.
- Kreiter SR, Schwartz RP, Kirkman HN Jr, Charlton PA, Calikoglu
AS, Davenport ML. Nutritional
rickets in African American breast-fed infants. J Pediatr 2000;137:153-157.
- Osiri M, Saag KG, Ford AM, Moreland LW. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. J Clin Rheum 2000;6:117-122.
- Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis
M, Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR,
Montaner LJ. Enhancement
of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses
in chronically infected persons after temporary treatment interruption.
J Infect Dis 2000;182:766-775.
- Smalley W, Shatin D, Wysowski DK, Gurwitz J, Andrade SE, Goodman
M, Chan KA, Platt R, Schech SD, Ray WA. Contraindicated
use of cisapride: impact of food and drug administration regulatory
action. JAMA 2000;284:3036-3039.
- Wesche DL, Schuster BG, Wang WX, Woosley RL. Mechanism
of cardiotoxicity of halofantrine. Clin Pharmacol Ther 2000;67:521-529.
To Top
|
